methylprednisolone and Neuroleptic Malignant Syndrome

methylprednisolone has been researched along with Neuroleptic Malignant Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asoh, T; Metoki, N; Sato, Y; Satoh, K1
Clarke, CE1
Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L1

Trials

1 trial(s) available for methylprednisolone and Neuroleptic Malignant Syndrome

ArticleYear
Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:5

    Topics: Aged; Antiparkinson Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Neuroleptic Malignant Syndrome; Neuroprotective Agents; Parkinson Disease; Pulse Therapy, Drug; Severity of Illness Index; Time Factors; Treatment Outcome

2003

Other Studies

2 other study(ies) available for methylprednisolone and Neuroleptic Malignant Syndrome

ArticleYear
Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:3

    Topics: Antiparkinson Agents; Humans; Incidence; Japan; Methylprednisolone; Neuroleptic Malignant Syndrome; Neuroprotective Agents; Parkinson Disease

2004
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
    Acta anaesthesiologica Scandinavica, 1999, Volume: 43, Issue:1

    Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; Calcium Channel Blockers; Dantrolene; Droperidol; Glucocorticoids; Halothane; Humans; Intubation, Intratracheal; Magnesium Sulfate; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Respiration, Artificial; Rhabdomyolysis

1999